Sunday, March 16, 2025
HomeIndustriesBiotechnology

Biotechnology

Lenzilumab Treatment Response in Hospitalized COVID-19 Patients Correlates with C-Reactive Protein Levels

Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, announced...

Onera Health Launches the Onera Biomedical-Lab-on-Chip™ at CES 2022

Onera Health announced Improved Pharma Contributes to Paper Advancing the Study of Sameness of Amorphous Materialsthe introduction of its first Onera Biomedical-Lab-on-Chip™. The biomedical...

Improved Pharma Contributes to Paper Advancing the Study of Sameness of Amorphous Materials

Improved Pharma continued collaboration with expert colleagues in the field of amorphous studies has resulted in a new publication. The article can be downloaded...

ABCT, Connecticut’s Newest Accelerator Program for Biosciences Ventures, Announces 2022 Cohort of Life Science Startups

ABCT, the Accelerator for Biosciences in Connecticut, announced the second cohort of emerging biosciences ventures invited to participate in the annual program. Nine ventures...

CStone Pharmaceuticals announced the IND approval of CS5001, a potential global best-in-class ROR1-targeting ADC by the U.S. Food and Drug Administration

CStone Pharmaceuticals, a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the...
0FansLike
0FollowersFollow
spot_img

Hot Topics